Table 1.
The dysregulated lncRNA in clinical OA samples.
LncRNA | Human tissue/cells | Expression in OA | Potential targets | Cellular process | Proposed molecular mechanism | References |
---|---|---|---|---|---|---|
H19 | OA Cartilage | Upregulated | COL2A1, COL9A1, COL10A1, CILP, and HTRA1 | ECM anabolism | miR675 host | (26) |
OA chondrocyte | Upregulated | PCNA, CyclinD1, and cleaved Caspase 3 | Cell proliferation | Interaction with miR106-5p | (27) | |
OA Cartilage | Upregulated | IL-38 | Inflammatory response | Interaction with p53 | (28) | |
OA Cartilage | Upregulated | Bax and Bcl2 | Cell apoptosis | Interaction with miR140-5p | (29) | |
COL2A1, MMP1, and MMP13 | ECM degradation | |||||
ALP, OCN, and BSP | Ossification | |||||
OA synovium | Upregulated | – | – | – | (30) | |
GAS5 | OA chondrocyte | Upregulated | MMP2, MMP3, MMP9, MMP13, and ADAMTS4 | ECM degradation | Interaction with miR21 in autophagy | (31) |
OA chondrocyte | Upregulated | Bax and Bcl2 | Cell apoptosis | Interaction with miR34a | (32) | |
OA Cartilage | Upregulated | Caspase 3, Bax, and Bcl 2 | Cell apoptosis | Interaction with miR137 | (33) | |
OA synovium | Downregulated | Caspase 3, and Bax | Cell apoptosis | – | (34) | |
MALAT1 | OA chondrocyte | Upregulated | ADAMTS5, COL2A1, ACAN, and COMP | ECM degradation | Interaction with miR145 | (35) |
OA Cartilage | Upregulated | OPN | Cell proliferation | Regulated PI3K/Akt pathway by interacting with miR127-5p | (36) | |
OA synoviocytes | Upregulated | IL-6 and CXCL8 | Inflammatory response | – | (37) | |
OA Subchondral bone | Upregulated | PGE2 | Inflammatory response | – | (38) | |
OA Cartilage | Upregulated | Cleaved caspase3 and Bcl2 | Cell apoptosis | Regulated DNMT3A by interacting with miR149-5p | (39) | |
COL2 and aggrecan | ECM degradation | |||||
OA Cartilage | Upregulated | Cleaved caspase3 and Bcl2 | Cell apoptosis | Regulated GNG5 by interacting with miR675-3p | (40) | |
COL2A1 and MMP13 | ECM degradation | |||||
IL-6 and IL-8 | Inflammatory response | |||||
OA Cartilage | Upregulated | CXCR4 | Cell proliferation | Regulated MAPK signaling by interacting with miR211 | (41) | |
OA synovium (Macrophagy) |
Upregulated | IL‐4, IL-6, IL-10, IL‐1β, and TNF‐α | Inflammatory response | Interaction with miR376 | (42) | |
ICAM1, MMP3, MMP9, and MRP8 | Migration | |||||
OPN, ACAN, and COL2 in chondrocyte | Crosstalk | |||||
HOTAIR | OA Cartilage | Upregulated | Bcl2, cleave caspase3, p62 and LC3B | Cell apoptosis | Regulated ADAM10 by interacting with miR222-3p | (43) |
COL2, COL10, SOX9, and MMP13, | ECM degradation | |||||
IL-6, IL-10 and TNF-α | Inflammatory response | |||||
OA Cartilage | Upregulated | Cleaved caspase3, Survivin, Bcl2 and Bax | Cell apoptosis | Regulated BCL2L13 by interacting with miR130a-3p | (44) | |
OA Cartilage | Upregulated | IL-1β and TNF-α | Inflammatory response | Regulated STGB by interacting with miR1277-5p | (45) | |
Aggrecan and COL2 | ECM degradation | |||||
OA Cartilage | Upregulated | Aggrecan, COL2, MMP13 and MMP9 | ECM degradation | Regulated CXCL12 by interacting with miR107 | (46) | |
– | Cell apoptosis | |||||
OA chondrocyte | Upregulated | ADAMTS5 MMP13, ADAMTS5, COL2, and ACAN |
ECM degradation | Interaction with promotor | (47) | |
OA Cartilage | Upregulated | Cleaved caspase3, cleaved caspase9 and Bax | ECM degradation | Regulated FUT2/WNT aixs by interacting with miR17-5p | (48) | |
Cell apoptosis | ||||||
OA Cartilage | Upregulated | COL2, MMP9, MMP13, TIMP3, ACAN and ADAMTS5 | ECM degradation | Regulated WIF1/WNT pathway | (49) | |
HOTTIP | OA chondrocyte | Upregulated | HoxA cluster | – | Epigenetic regulation | (50) |
OA Cartilage | Upregulated | – | Cell proliferation | Regulated FRK by interacting with miR 663a | (51) | |
CIR | OA Cartilage | Upregulated | MMP13, ADAMTS5, COL2, COL1, and ACAN | ECM degradation | Vimentin inhibition | (52) |
OA chondrocyte | Upregulated | MMP13 | ECM degradation | Interaction with miR27 | (53) | |
OA Cartilage | Upregulated | COL2A1, and MMP13 | ECM degradation | Activating autophagy | (54) | |
MSR | OA Cartilage | Upregulated | COL2A1, ACAN, MMP13, and ADAMTS5 | ECM degradation | Regulated TMSB4 by interacting with miR152 | (55) |
PVT1 | OA Cartilage | Upregulated | COL2, ACAN, MMP3, MMP9 and MMP13 | ECM degradation | Interaction with miR149 | (56) |
PGE2, NO, IL-6, IL-8, and TNF-α | Inflammatory response | |||||
OA Cartilage | Upregulated | Cleaved caspase3 and autophagy | Cell apoptosis | Regulated TRAF3 by interacting with miR27b-3p | (57) | |
OA synovium | Upregulated | Caspase 3, and Bax | Cell apoptosis | – | (34) | |
Nespas | OA chondrocyte | Upregulated | COL2, COL1, MMP2 and MMP13 | ECM degradation | Interaction with miRNAs | (58) |
UCA1 | OA Cartilage | Upregulated | COL2, COL4, and MMP13 | ECM degradation | Interaction with miR204-5p | (59) |
– | Cell proliferation | |||||
DANCR | OA Cartilage | Upregulated | Caspase3 and Bcl2 | Cell apoptosis | Regulated SphK2 by competing with miR577 | (60) |
OA Cartilage | Upregulated | IL-6 and IL-8 | Inflammatory response | Regulated JAK2/STAT3 signaling by interacting with miR216a-5p | (61) | |
OA Cartilage | Upregulated | IL-1, IL-6, IL-8, and TNF-α | Inflammatory response | Regulated DANCR by interacting with miR19a | (62) | |
– | Cell apoptosis | |||||
LncHIFCAR | OA Cartilage | Upregulated | MMP1, MMP3 and MMP13 | ECM degradation | Regulated HIF-1α, HIF-1α target genes, and PI3K/AKT/mTOR pathway | (63) |
TNF-α and IL-6 | Inflammatory response | |||||
Bcl2, Bax, and Cytochrome C | Cell proliferation | |||||
FAS-AS1 | OA Cartilage | Upregulated | COL2, MMP1 and MMP13 | ECM degradation | – | (64) |
– | Cell proliferation | – | ||||
FOXD2-AS1 | OA Cartilage | Upregulated | CCND1 | Cell proliferation | Interaction with miR206 | (65) |
p21 | OA chondrocyte | Upregulated | Bcl2, and Bax | Cell apoptosis | Interaction with miR451 | (66) |
TM1P3 | OA chondrocyte | Upregulated | MMP13 | ECM degradation | Regulated TGF-β signaling by interacting with miR22 | (67) |
TNFSF10 | OA chondrocyte | Upregulated | IL-6 and IL-8 | Inflammatory response | Regulated FGFR1 by interacting with miR376-3p | (68) |
– | Cell proliferation | |||||
– | Cell apoptosis | |||||
LINC01534 | OA Cartilage | Upregulated | MMP3, MMP9, MMP13, COL2 and aggrecan | ECM degradation | Interaction with miR140-5p | (69) |
NO, PGE2, TNF-α, IL-6, and IL-8 | Inflammatory response | |||||
NKILA | OA Cartilage | Upregulated | Bcl2, Bax, and cleaved caspase3 | Cell apoptosis | Regulated SP1/NF-κB axis by interacting with miR145 | (70) |
LINC00461 | OA Cartilage | Upregulated | IL-6, IL-10 | Inflammatory response | Interaction with miR30a-5p | (71) |
COL2, MMP2, MMP3 and MMP13 | ECM degradation | |||||
– | Cell proliferation | |||||
LOXL1-AS1 | OA Cartilage | Upregulated | Cleaved Caspase 3, Cleaved Caspase 9, and Bax | Cell apoptosis | Regulated KDM5C by interacting with miR423-5p | (72) |
IL-6, IL-8 | Inflammatory response | |||||
PCAT-1 | OA chondrocyte | Upregulated | Cleaved Caspase3, Bcl2, and Bax | Cell apoptosis | Interaction with miR27b-3p | (73) |
ARFRP1 | OA Cartilage | Upregulated | CCND1, Bcl2, and Bax | Cell apoptosis | Regulated TLR4/NF-κB axis by interacting with miR15a-5p | (74) |
TNF-α, IL-6, and IL-1β | Inflammatory response | |||||
TUG1 | OA Cartilage | Upregulated | MMP13, COL2 and aggrecan | ECM degradation | Regulated FUT1 by interacting with miR17-5p | (75) |
– | Cell apoptosis | |||||
LINC00671 | OA Cartilage | Upregulated | Col2A1, Aggrecan, MMP3, MMP13, ADAMTS4, and ADAMTS5 | ECM degradation | Regulated ONECUT2/Smurf2/GSK-3β axis | (76) |
RMRP | OA Cartilage | Upregulated | – | Cell proliferation | Regulated CDK9 by interacting with miR206 | (77) |
KCNQ1OT1 | OA Cartilage | Upregulated | IL-1β, TNF-α and IL-6 | Inflammatory response | Regulated TCF4 by interacting with miR211-5p | (78) |
COL2, COL10, and MMP13 | ECM degradation | |||||
OA Cartilage | Downregulated | COL2, and MMP13 | ECM degradation | Regulated TRPS1 by interacting with miR126-5p | (79) | |
– | Cell proliferation | |||||
RP11-364P22.2 | OA Cartilage | Upregulated | Col2A1, Aggrecan, and MMP13 | ECM degradation | Regulated ATF3 | (80) |
Caspase3, and NF-κB | Cell apoptosis | |||||
Cox2 | OA Cartilage | Upregulated | Ki67 and PCNA | Cell proliferation | Regulated Wnt/β-catenin pathway by interacting with miR150 | (81) |
Caspase3, Caspase9, and Bax | Cell apoptosis | |||||
CASC19 | OA Cartilage | Upregulated | IL-6, IL-8, and TNF-α | Inflammatory response | Regulated DDX6 by interacting with miR152-3p | (82) |
– | Cell apoptosis | |||||
MIR22HG | OA Cartilage | Upregulated | COL2A1, ACAN, MMP13, ADAMTS5 | ECM degradation | Interaction with miR9-3p | (83) |
– | Cell apoptosis | |||||
LINC01385 | OA Cartilage | Upregulated | IL-6, TNF-α, PGE2 | Inflammatory response | Interaction with miR 140-3p/TLR4 axis | (84) |
LINC00707 | OA Cartilage | Upregulated | – | Cell apoptosis | Interaction with miR199-3p | (85) |
OA Cartilage | Upregulated | – | Cell apoptosis | Regulated FSHR by interacting with miR330-5p | (86) | |
COL2, ACAN, MMP13, MMP3 | ECM degradation | |||||
IL-6, TNF-α | Inflammatory response | |||||
LINC00680 | OA Cartilage | Upregulated | – | Cell proliferation | Regulated SIRT1 by interacting with IGF2BP2 | (87) |
COL2, ACAN, MMP13, | ECM degradation | |||||
PILA | OA Cartilage | Upregulated | MMP13, MMP3, ADAMTS4 | ECM degradation | Regulated TAK1/NF-κB aixs by interacting with PRMT1 | (88) |
– | Cell apoptosis | |||||
DLEU1 | OA Cartilage | Upregulated | COL2, ACAN, ADAMTS5 and MMP3 | ECM degradation | Interaction with miR671-5p | (89) |
IL‐1, IL‐6, and TNF-α | Inflammatory response | |||||
MEG3 | OA Cartilage | Downregulated | VEGF | Angiogenesis | – | (90) |
OA chondrocyte | Downregulated | Ki67 and PCNA | Cell proliferation | Regulated FOXO1 by interacting with miR361-5p | (91) | |
Bcl2 and Bax | Cell apoptosis | |||||
MMP13, ADAMTS5, COL2, ACAN | ECM degradation | |||||
CILinc01 | OA chondrocyte | Downregulated | IL-6 | Inflammatory response | – | (92) |
CILinc02 | OA Cartilage | Upregulated | IL‐1, IL‐6, and IL‐17 | Inflammatory response | – | (93) |
TIMP1, MMP1 and MMP13 | ECM degradation | – | ||||
– | Cell apoptosis | – | ||||
UFC1 | OA Cartilage | Downregulated | – | Cell proliferation | Interaction with miR34a | (94) |
SNHG5 | OA Cartilage | Downregulated | SOX2 | Cell proliferation | Interaction with miR26a | (95) |
OA Cartilage | Downregulated | MMP13, ADAMTS5, COL3 and ACAN | ECM degradation | Regulated autophagy by interacting with miR141-3p | (96) | |
Cleaved caspase3 | Cell apoptosis | |||||
OA Cartilage | Downregulated | Cleaved caspase3, and cleaved caspase9 | Cell apoptosis | Regulated H3F3B by interacting with miR10a-5p | (97) | |
COL2, and ADAMTS5 | ECM degradation | |||||
OA Cartilage | Upregulated | MMP13 and ADAMTS5 | ECM degradation | |||
Regulated TGFBR3 by interacting with miR181a‐5p | (98) | |||||
Caspase3 | Cell apoptosis | |||||
HOTAIRM1-1 | OA Cartilage | Downregulated | – | Chondrogenic differentiation | Regulated BMPR2/MAPK aixs by interacting with miR125b | (99) |
Cleaved caspase3, cleaved caspase9, Bcl2 and Bax | Cell apoptosis | |||||
COL2, COL10, and aggrecan | ECM degradation | |||||
LINC00341 | OA Cartilage | Downregulated | Bcl2, and Bax | Cell apoptosis | Regulated YAF2 by interacting with miR141 | (100) |
DNM3OS | OA Cartilage | Downregulated | Cleaved caspase3, Bcl2, and Bax | Cell proliferation | Regulated IGF1 by interacting with miR126 | (101) |
PART1 | OA Cartilage | Downregulated | Cleaved caspase3, cleaved caspase9 and Bax | Cell apoptosis | Regulated TGFBR2/Smad3 axis by interacting with miR590-3p | (102) |
OA Cartilage | Downregulated | MMP13, COL2, and ACAN | ECM degradation | Regulated SOX4 by interacting with miR373-3p | (103) | |
Bcl2, Bax and cleaved caspase3 | Cell apoptosis | |||||
NEAT1 | OA Cartilage | Downregulated | ACAN, Col2a1, MMP3, MMP13, and ADAMTS5 | ECM degradation | Regulated SOX5 by interacting with miR373-3p | (104) |
IL-1, TNF-α, IL-6, and IL-8 | Inflammatory response | |||||
– | Cell apoptosis | |||||
OA Cartilage | Upregulated | MMP3, MMP9, and MMP13 | ECM degradation | Regulated PLA2G4A by interacting with miR543 | (105) | |
IL-6, and IL-8 | Inflammatory response | |||||
p-Akt1 and Bcl2 | Cell proliferation | |||||
LINC00662 | OA chondrocyte | Downregulated | TNF‐α, IL‐6, and IL‐8 | Inflammatory response | Regulated GPR120 by interacting with miR15b-5p | (106) |
Cleaved caspase3, cleaved caspase9 and Bax | Cell apoptosis | |||||
OIP5-AS1 | OA Cartilage | Downregulated | IL-6, IL-8, and TNF-α | Inflammatory response | Regulated PGRN by interacting with miR29b-3p | (107) |
Bax | Cell apoptosis | |||||
LINC00623 | OA Cartilage | Downregulated | MMP13, and COL2 | ECM degradation | Regulated HRAS/MAPK axis by interacting with miR101 | (108) |
Cleaved caspase3, and cleaved caspase7 | Cell apoptosis | |||||
SNHG7 | OA Cartilage | Downregulated | Cleaved Caspase3, Cleaved Caspase7 | Cell apoptosis | Regulated SNHG7/PPARγ axis by interacting with miR214-5p | (109) |
IL-1β, TNF-α and IL-6 | Inflammatory response | |||||
ROR | OA Cartilage | Downregulated | COL2, ACAN, MMP13 and COL10 | Chondrogenesis | Regulated SOX9 by interacting with miR138 and miR145 | (110) |
OIP5-AS1 | OA Cartilage | Downregulated | Caspase 3, Caspase 9, Bax, and Bcl2 | Cell apoptosis | Interaction with miR30a-5p | (111) |
IL-6, IL-8, and TNF-a | Inflammatory response | |||||
FGD5-AS1 | OA Cartilage | Downregulated | – | Cell apoptosis | Regulated TGFBR2 by interacting with miR302d-3p | (112) |
MCM3AP-AS1 | OA Cartilage | Downregulated | – | Cell apoptosis | Regulated SIRT1 by interacting with miR138-5p | (113) |
MEG8 | OA Cartilage | Downregulated | Caspase3 | Cell apoptosis | Regulated PI3K/AKT signaling | (114) |
IL-6 and TNF-α | Inflammatory response | |||||
ZFAS1 | OA Cartilage | Downregulated | ROS, SOD, and Catalase | Oxidative stress | Regulated NRF2 by interacting with miR1323 | (115) |
IL-1β, TNF-α and IL-6 | Inflammatory response | |||||
– | Cell apoptosis | |||||
GACAT3 | OA synoviocytes | Upregulated | Caspase3 | Cell proliferation | Regulated STAT3 | (116) |
ANRIL | OA synoviocytes | Upregulated | Cleaved caspase3, Bax, and Bcl2 | Cell proliferation | Regulated DUSP4 by interacting with miR122-5p | (117) |
PCGEM1 | OA synoviocytes | Upregulated | PARP and caspase9 | Cell proliferation | Interaction with miR770 | (118) |
OA synoviocytes | Upregulated | Chondrocyte apoptosis and cartilage matrix degradation | Crosstalk | Interaction with miR142-5p | (119) | |
AK094629 | OA synovium | Upregulated | IL-6 | Inflammatory response | Regulated MAP3K4 | (120) |
IGHCγ1 | PBMCs | Upregulated | IL-6 and TNF-α | Inflammatory response | Regulated TLR4/NF-κB axis by interacting with miR6891-3p | (121) |
AC005165.1 | OA Subchondral bone | Downregulated | – | – | Regulated FRZB/WNT signaling | (122) |
LOC107986251 | OA Menisci | Upregulated | – | – | Regulated SESN3 by interacting with miR212-5p | (123) |
COL, Collagen; CILP, Cartilage intermediate layer protein; ECM, Extracellular matrix; PCNA, Proliferating cell nuclear antigen; MMPs, Matrix metalloproteinases; ALP, Alkaline phosphatase; OCN, Osteocalcin; BSP, Bone sialoprotein; ACAN, Aggrecan; ADAMTS, A disintegrin and metalloproteinase with thrombospondin motifs; COMP, Cartilage oligomeric matrix protein; PGE2, Prostaglandin E2; OPN, Osteopontin; TIMPs, Tissue inhibitor of metalloproteinases; CXCL, C-X-C Motif Chemokine Ligand; CXCR, C-X-C chemokine receptor; MRP, Multidrug resistance-associated protein; CCND1, Cyclin D1; VEGF, Vascular endothelial growth factor; ROS, Reactive oxygen species; SOD, Superoxide Dismutase; PBMCs, Peripheral Blood Mononuclear Cells.